A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer
Keyword(s):
Phase 2
◽
2015 ◽
Vol 51
(4)
◽
pp. 383-388
◽
2010 ◽
Vol 267
(9)
◽
pp. 1423-1428
◽
2011 ◽
Vol 227
(2)
◽
pp. 467-473
◽
Keyword(s):
2011 ◽
Vol 2011
◽
pp. 18-19
Keyword(s):
2018 ◽
Vol 124
◽
pp. 11-20
◽
Keyword(s):